DYSPORT THERAPEUTIC

ipsen biopharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 09f996cdf4557b5b
Drug Approval Canada Name: DYSPORT THERAPEUTIC
Product Name: DYSPORT THERAPEUTIC
Status: Marketed
Status Date: 2022-04-06
Original Market Date: 2017-02-27
Din: 02460203
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intramuscular
Schedule: Schedule D , Prescription
Ahfs: 12:20.20.24
Atc Original: M03AX01 BOTULINUM TOXIN
Atc Name: m 03 ax 01
Aig Number: 0153614001
Company Name: ipsen biopharmaceuticals canada inc
Company Address: SUITE 500, 5050 Satellite Drive, Mississauga, Ontario, Canada, L4W 0G1

ABOBOTULINUMTOXINA

300 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

09f996cdf4557b5b

Type

Standard